Cvs Health CORP Form 4 insider transactions

Director Anne Finucane reports acquisition of CVS Health common stock and deferred stock units related to director compensation.

Alecia A. DeCoudreaux, a director of CVS Health Corp, acquired deferred stock units equivalent to 2,077.4764 shares of common stock on May 15, 2025, as part of the company's non-employee director compensation policy.

C David Brown II, a director of CVS Health Corp, acquired 2,232 shares of common stock at a price of $60.47 per share on May 15, 2025, as part of the company's 2017 Incentive Compensation Plan.

Jeffrey R. Balser, a director of CVS Health Corp, acquired 2,232 shares of common stock as part of the company's incentive compensation plan.

Fernando Aguirre, a director at CVS Health, acquired 2,263 shares of common stock as part of the company's 2017 Incentive Compensation Plan.

J. David Joyner, President and CEO of CVS Health, files an amendment to a previous SEC Form 4 to correct the type and number of securities granted, clarifying that he received restricted stock units (RSUs) instead of stock options.

Larry Robbins, a Director of CVS Health Corp, reports selling shares of the company's common stock held by Glenview Investment Funds between May 2 and May 6, 2025.

EVP and Group President Prem S. Shah reports acquisition and disposal of CVS Health Corp stock and stock options.

EVP and President of Aetna, Steven Nelson, reports acquisition of restricted stock units and stock options in CVS Health Corp.

EVP Tilak Mandadi reports acquisition of restricted stock units and stock options, along with the surrender of shares for tax withholding.

EVP, CPO and General Counsel of CVS Health, Samrat S. Khichi, reports acquisition and disposal of CVS stock and stock options.

J. David Joyner, President and CEO of CVS Health, reports the acquisition of stock options and the surrender of shares for tax withholding.

Thomas F. Cowhey, EVP and CFO of CVS Health, reports acquisition and disposal of CVS stock and stock options.

SVP, Controller & Chief Accounting Officer of CVS Health, James David Clark, reports acquisition and disposal of CVS common stock and restricted stock units.

EVP and Chief People Officer of CVS Health, Heidi B. Capozzi, reports the acquisition of restricted stock units and stock options.

Prem S. Shah, EVP and Group President at CVS Health, exercised stock options on March 17, 2025, acquiring 846 shares of common stock at $62.21 per share.

Anne Finucane, a director at CVS Health, filed an amended Form 4 to correct previous reporting errors related to a gift of shares and the holding of shares in a trust.

SVP, Controller & Chief Accounting Officer James David Clark reports the exercise of stock options and subsequent sale of CVS Health Corp shares on March 5, 2025.

Samrat S. Khichi, EVP, CPO and General Counsel of CVS Health Corp, reports the surrender of shares for payment of withholding taxes on a restricted stock award.

J. David Joyner, President and CEO of CVS Health Corp, reported the surrender of 1,944 common stock shares to cover withholding taxes upon the vesting of a restricted stock award on February 28, 2025.

Thomas Cowhey, EVP and CFO of CVS Health, reported the surrender of 5,318 common stock shares to cover withholding taxes upon vesting of a restricted stock award on February 28, 2025.

Director Michael F. Mahoney of CVS Health Corp reports purchasing 30,000 shares of common stock at $66.70 per share on February 18, 2025.

J. David Joyner, President and CEO of CVS Health, amends a previous SEC filing to clarify the details of stock options and stock appreciation rights granted to him.

CVS Health director Anne A. Finucane gifted 2,665 shares of common stock to a donor-advised charitable family foundation on December 5, 2024.

James David Clark, SVP, Controller & Chief Accounting Officer at CVS Health, reported a transaction involving the withholding of shares to cover FICA taxes.

CVS Health director Roger Farah reported the acquisition of 50,125 restricted stock units and the disposal of 4,124.4534 common stock shares.

CVS Health's Executive Vice President and Chief People Officer, Heidi B. Capozzi, acquired 83,542 restricted stock units on November 30, 2024.

CVS Health EVP and President of Aetna, Steven H. Nelson, acquired 124,378 stock options on November 30, 2024.

CVS Health CEO J. David Joyner reported the acquisition of premium stock options and the disposal of common stock and restricted stock.

CVS Health EVP and Group President Prem S. Shah reports a large grant of premium stock options, alongside existing holdings of common stock and other derivative securities.